Hamilton Thorne Ltd. (CVE:HTL – Get Free Report) shares traded up 4.3% on Tuesday. The company traded as high as C$1.45 and last traded at C$1.45. 25,700 shares changed hands during trading, a decline of 27% from the average daily volume of 35,118 shares. The stock had previously closed at C$1.39.
Hamilton Thorne Stock Up 4.3%
The company has a debt-to-equity ratio of 43.24, a quick ratio of 2.25 and a current ratio of 2.04. The stock’s fifty day simple moving average is C$1.45 and its two-hundred day simple moving average is C$1.45. The stock has a market capitalization of C$149.69 million, a P/E ratio of 58.94 and a beta of 0.54.
About Hamilton Thorne
Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. It offers precision laser systems, imaging systems, and other equipment and consumables for the ART and developmental biology research markets. The company also provides test laboratory and endotoxin testing services, as well as sperm assays, including Sperm Motility Index and Sperm Penetration; and fresh and cryopreserved mouse embryos supply, and technician training and proficiency testing services.
Further Reading
- Five stocks we like better than Hamilton Thorne
- Aurora Rejects Curaleaf’s Higher Bid, But the Takeover Fight Isn’t Over
- Centrus Energy Is Building a Nuclear Fuel Powerhouse—Why Is Its Stock Struggling?
- Halliburton Gains Traction: Multiyear Upcycle Ahead
- Meta Platforms’ AI Comeback Faces an Earnings Test—And a $10 Billion Charge
Receive News & Ratings for Hamilton Thorne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hamilton Thorne and related companies with MarketBeat.com's FREE daily email newsletter.
